Table 2.

Serological and virological characteristics of the samples with positive ELISA results.

ID	OD ELISA SARS	OD ELISA HIV	HIV LFA	Western blot	HIV viral load	Observation
COVID19-039	3.4063	0.415	NEG	NEG	TND	HTN
COVID19-090	4	0.258	NEG	NEG	TND	No comorbidities
COVID19-118	4	0.301	NEG	NEG	TND	Asthma
COVID19-149	3.6887	0.62	NEG	NEG	TND	No comorbidities
COVID19-177	3.7	0.948	NEG	NEG	TND	No comorbidities
COVID19-251	1.2494	0.671	NEG	NEG	TND	No comorbidities
COVID19-279	1.1003	3.454	POS	gp120, gp41, p24	< 40 cp/ml	Under ART
COVID19-293	3.9679	0.46	NEG	NEG	TND	No Comorbidities
COVID19-520	3.892	0.301	NEG	NEG	TND	HTN
COVID19-525	2.78	3.46	NEG	NEG	TND	SLE
COVID19-585	0.3993	3.468	POS	gp120, pg41, p51, p31, p24, p17	< 40 cp/ml	Under ART
COVID19-711	0.2466	3.477	POS	gp120, gp41, p51, p31, p24	35.296 cp/ml	No ART
COVID19-824	0.2582	2.329	NEG	NEG	TND	No comorbidities
COVID19-842	0.3116	3.465	NEG	NEG	TND	No comorbidities
COVID19-984	2.1038	0.266	NEG	NEG	TND	No comorbidities

ART, antiretroviral therapy; HTN, arterial hypertension; LFA, lateral flow assay; OD, optical density; SLE, systemic lupus erythematosus; TND, target not detected.